P23443

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession KS6B1_HUMAN; P23443;
Entrez ID 6198
GenBank Protein ID NM_001272042.1; NM_001272043.1; NM_001272044.1; NM_001272060.1; NM_003161.3;
GenBank Nucleotide ID NP_001258971.1; NP_001258972.1; NP_001258973.1; NP_001258989.1; NP_003152.1;
Protein Name Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (
Gene Name RPS6KB1; STK14A
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionSerine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex (view all)
Sequence
(Fasta)
MRRRRRRDGF YPAPDFRDRE AEDMAGVFDI DLDQPEDAGS EDELEEGGQL NESMDHGGVG 60
PYELGMEHCE KFEISETSVN RGPEKIRPEC FELLRVLGKG GYGKVFQVRK VTGANTGKIF 120
AMKVLKKAMI VRNAKDTAHT KAERNILEEV KHPFIVDLIY AFQTGGKLYL ILEYLSGGEL 180
FMQLEREGIF MEDTACFYLA EISMALGHLH QKGIIYRDLK PENIMLNHQG HVKLTDFGLC 240
KESIHDGTVT HTFCGTIEYM APEILMRSGH NRAVDWWSLG ALMYDMLTGA PPFTGENRKK 300
TIDKILKCKL NLPPYLTQEA RDLLKKLLKR NAASRLGAGP GDAGEVQAHP FFRHINWEEL 360
LARKVEPPFK PLLQSEEDVS QFDSKFTRQT PVDSPDDSTL SESANQVFLG FTYVAPSVLE 420
SVKEKFSFEP KIRSPRRFIG SPRTPVSPVK FSPGDFWGRG ASASTANPQT PVEYPMETSG 480
IEQMDVTMSG EASAPLPIRQ PNSGPYKKQA FPMISKRPEH LRMNL 526

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationOsteogenic sarcoma/OsteosarcomaP23879172
[Reference]: FIM-A treatment resulted in the inhibition of mTORC1 signaling as demonstrated by the decreased phosphorylation of p70S6K1 and 4E-BP1. Consistent with this finding, FIM-A significantly decreased the average tumor volume, nuclei staining of PCNA, and the number of intratumoral microvessels
2PhosphorylationAmeloblastomaP22977662
[Reference]: he nuclear expression of p-mTOR, p-4E-BP1 and p-p70S6K was associated with biological behaviors (invasiveness) of ABs, and p-mTOR was an independent predictor of AB
3PhosphorylationGallbladder cancerU24124380
[Reference]: AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines;
4PhosphorylationHepatocellular carcinoma/Hepatocarcinoma/HepatomaU23934262
[Reference]: Both of the compounds decreased the phosphorylation levels of p70 ribosomal protein S6 kinase (S6K) and eIF4E binding protein 1 (4E-BP1), resulting in cancer cell cytotoxicity and apoptosis
5PhosphorylationLung adenocarcinomaU23934262
[Reference]: Both of the compounds decreased the phosphorylation levels of p70 ribosomal protein S6 kinase (S6K) and eIF4E binding protein 1 (4E-BP1), resulting in cancer cell cytotoxicity and apoptosis
6PhosphorylationBreast cancer/tumor/carcinomaU24023352; 23794518
[Reference]: Lapatinib increased the phosphorylation of AMPK at Thr172 with time- and dose-dependent manner
7PhosphorylationNon-small cell lung cancer/carcinomaU23886172
[Reference]: The expression level of p-mTOR and p-RPS6KB1 was significantly higher in NSCLC tumor specimens than that in adjacent noncancerous normal lung tissues (P<0.01)
8PhosphorylationChronic myelogenous leukemia/Chronic myeloid leukemiatumor tissueU23384908
[Reference]: The phosphorylation of mTOR, 4E-BP1 and p70S6K were significantly increased in CML bone marrow cells compared with that of normal control (70.6% vs 30.0%, 76.5% vs 40.0%, 73.5% vs 20.0%, respectively, P < 0.05)
9Threonine PhosphorylationLiver cancercell linePT38923537100
[Reference]: CCI-779 inhibited the phosphorylation of mTOR (Ser2448), p70S6K (Thr389), S6 (Ser240/244), and 4EBP1 (Thr37/46) in different grades and the expressions of p70S6K, S6, and 4EBP1. As a result, CCI-779 induced a dose-dependent decrease in cell proliferation, G1/S arrest and damage of cell shape
10Threonine PhosphorylationOvarian cancer/carcinomaUT41221276607
[Reference]: Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer.
11Threonine PhosphorylationAlzheimer's diseasePT44416364302
[Reference]: p70S6K T421/S424 phosphorylation correlates with tau phosphorylation in AD brains

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 5)
MESH:D001284 ; Atrophy
MESH:C537948 ; Ceroid lipofuscinosis, neuronal 1, infantile
MESH:D006973 ; Hypertension
MESH:D017379 ; Hypertrophy, Left Ventricular
MESH:D016403 ; Lymphoma, Large B-Cell, Diffuse
HGMD
(count: 2)
CD072467; Protein kinase deficiency; Small deletions
CD072468; Protein kinase deficiency; Small deletions
GWASdb
(count: 5)
rs2526354; Multiple complex diseases; Null
rs2526354; Arthritis (juvenile idiopathic); juvenile rheumatoid arthritis
rs2531899; Obesity-related traits; obesity
rs180515; Multiple sclerosis; multiple sclerosis
rs1051424; Obesity-related traits; obesity

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 25)
(view all)
235       HQGHVKLTDFGLCKE     dbPAF
243       DFGLCKESIHDGTVT     dbPAF
248       KESIHDGTVTHTFCG     dbPAF
250       SIHDGTVTHTFCGTI     dbPAF
252       HDGTVTHTFCGTIEY     dbPAF
256       VTHTFCGTIEYMAPE     dbPAF
Acetylation
(count: 2)
304       NRKKTIDKILKCKLN     PLMD
516       QAFPMISKRPEHLRM     PLMD
Ubiquitination
(count: 4)
104       LGKGGYGKVFQVRKV     PLMD
135       AMIVRNAKDTAHTKA     PLMD
450       RTPVSPVKFSPGDFW     PLMD
99        ELLRVLGKGGYGKVF     PLMD
Malonylation
(count: 1)
304       NRKKTIDKILKCKLN     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource